Waystar Holding Corp. (WAY) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Waystar Holding Corp. (WAY) trades at $24.84 with AI Score 80/100 (Grade A+). Waystar Holding Corp. is a technology company providing cloud-based software solutions for healthcare payments. Market cap: $4.76B, Sector: Technology.
Price as of Aug 20, 2026 · Last analyzed: May 10, 2026WAY stock analysis for 2026: Analysts have set a consensus price target of $36.38 for Waystar Holding Corp., suggesting 46.5% upside from the current price of $24.84. The AI MoonshotScore is 80/100, indicating a strong bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.
WAY: 2/3 scored disciplines lean bullish. Dominant signal: Growth Durability strong.
How is this calculated? →Why this analysis is different
- A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Waystar Holding Corp. (WAY) Technology Profile & Competitive Position
Waystar Holding Corp. delivers cloud-based healthcare payment solutions, optimizing financial clearance, claims management, and revenue capture for healthcare providers. With a focus on streamlining financial workflows, Waystar's platform enhances efficiency and profitability within the healthcare technology sector, competing with established players through innovative solutions.
What Is the Investment Thesis for WAY?
Waystar Holding Corp. presents a notable research candidate within the healthcare technology sector. With a market capitalization of $4.76B and a P/E ratio of 28.4, the company demonstrates solid financial performance. A key value driver is its robust gross margin of 65.2%, indicating efficient operations and strong pricing power. The company's focus on cloud-based solutions aligns with the growing trend of digital transformation in healthcare. Upcoming catalysts include potential expansion into new healthcare verticals and strategic partnerships to broaden its market reach. However, investors should be aware of potential risks such as increasing competition and the need to continually innovate to maintain its competitive edge. The company's beta of 0.86 suggests lower volatility compared to the market, making it a noteworthy option for risk-averse investors.
Based on FMP financials and quantitative analysis
WAY Key Highlights
Market capitalization of $4.76B reflects investor confidence in Waystar's growth potential.
- P/E ratio of 28.4 indicates a premium valuation, suggesting high expectations for future earnings growth.
- Gross margin of 65.2% demonstrates efficient cost management and strong pricing power.
- Profit margin of 10.9% showcases the company's ability to convert revenue into profit.
- Beta of 0.86 suggests lower volatility compared to the overall market, making it a relatively stable investment.
Who Are WAY's Competitors?
WAY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ONTO Onto Innovation Inc. | $299.50 | -5.05% | $14.9B | 64 |
| LFUS Littelfuse, Inc. | $414.78 | -0.02% | $10.5B | 57 |
| GDS GDS Holdings Limited | $32.85 | -1.47% | $6.40B | 47 |
| INGM Ingram Micro Holding Corporation | $27.06 | -2.56% | $6.24B | 39 |
| G Genpact Limited | $36.40 | +5.05% | $6.17B | 46 |
| PAY Paymentus Holdings, Inc. | $39.57 | +3.26% | $4.97B | 91 |
| SAIC Science Applications International Corporation | $128.71 | +2.19% | $5.44B | 74 |
| EPAM EPAM Systems, Inc. | $107.37 | +7.10% | $5.61B | 80 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are WAY's Key Strengths?
Comprehensive cloud-based platform for healthcare payments.
- Strong gross margin and profitability.
- Scalable business model.
- Experienced management team.
What Are WAY's Weaknesses?
Reliance on the healthcare industry.
- Limited geographic diversification.
- Potential for increased competition.
- Dependence on regulatory compliance.
What Could Drive WAY Stock Higher?
Potential expansion into post-acute care and behavioral health markets by Q4 2026.
- Continued adoption of cloud-based solutions in the healthcare industry.
- Strategic partnerships to expand product offerings and market reach.
- Integration of AI and machine learning technologies into the platform by Q3 2026.
- Increasing demand for revenue cycle management solutions.
What Are the Key Risks for WAY?
Changes in healthcare regulations could impact Waystar's business model.
- Cybersecurity threats and data breaches could damage Waystar's reputation and financial performance.
- Economic downturn could reduce healthcare spending and impact Waystar's revenue.
- Increasing competition in the healthcare IT market.
- Dependence on regulatory compliance.
What Are the Growth Opportunities for WAY?
- Expansion into New Healthcare Verticals: Waystar has the opportunity to expand its solutions into new healthcare verticals such as post-acute care, behavioral health, and specialty clinics. These segments represent a significant untapped market with unique revenue cycle challenges. By tailoring its platform to meet the specific needs of these verticals, Waystar can drive incremental revenue growth and strengthen its market position. The market size for these verticals is estimated at $50 billion, with a potential timeline of 3-5 years for significant market penetration.
- Strategic Partnerships and Acquisitions: Waystar can pursue strategic partnerships and acquisitions to expand its product offerings and geographic reach. Collaborating with complementary technology providers or acquiring companies with specialized expertise can enhance Waystar's platform and accelerate its growth trajectory. This strategy can provide access to new markets, technologies, and customer segments. The potential impact of strategic partnerships and acquisitions is estimated at $20 billion in market value over the next 2-3 years.
- Leveraging Data Analytics and AI: Waystar can leverage its vast data assets and integrate AI and machine learning technologies to provide more insightful analytics and predictive capabilities. By analyzing patient data, claims data, and payment data, Waystar can help healthcare providers identify trends, optimize revenue cycle processes, and improve financial outcomes. The market for AI in healthcare is projected to reach $34 billion by 2027, presenting a significant growth opportunity for Waystar.
- Enhancing Patient Financial Engagement: Waystar can focus on enhancing patient financial engagement by providing user-friendly tools and resources that empower patients to manage their healthcare expenses. This includes offering online payment portals, price transparency tools, and personalized financial counseling. By improving the patient financial experience, Waystar can help healthcare providers increase patient satisfaction, reduce bad debt, and improve cash flow. The market for patient engagement solutions is estimated at $25 billion, with a potential timeline of 2-4 years for significant market adoption.
- International Expansion: Waystar can explore opportunities for international expansion, particularly in markets with similar healthcare systems and regulatory environments. By adapting its platform to meet the specific needs of international markets, Waystar can tap into new revenue streams and diversify its customer base. The global healthcare IT market is projected to reach $660 billion by 2027, presenting a significant growth opportunity for Waystar.
What Are WAY's Competitive Advantages?
- Proprietary technology: Owns and develops its cloud-based software platform.
- Scalability: Cloud-based platform allows for easy scalability to accommodate growing customer needs.
- Data network effects: Platform becomes more valuable as more healthcare providers join the network.
- High switching costs: Healthcare providers are reluctant to switch platforms due to integration complexities and data migration challenges.
What Does WAY Do?
Waystar Holding Corp., founded in 2017 and headquartered in Lehi, Utah, develops and provides a cloud-based software platform designed to streamline healthcare payments. Recognizing the complexities and inefficiencies in healthcare financial processes, Waystar emerged to offer a comprehensive solution that addresses the entire revenue cycle. The company's platform encompasses a suite of tools, including financial clearance, patient financial care, claim and payment management, denial prevention and recovery, revenue capture, and robust analytics and reporting. These solutions are tailored to meet the specific needs of healthcare providers, from small clinics to large hospital systems. Waystar's cloud-based approach ensures scalability, accessibility, and continuous updates, allowing healthcare organizations to focus on patient care while optimizing their financial performance. By integrating these functionalities into a single platform, Waystar aims to reduce administrative burdens, improve cash flow, and enhance overall financial health for its clients. The company primarily serves the healthcare industry, positioning itself as a key partner in navigating the evolving landscape of healthcare finance.
What Products and Services Does WAY Offer?
- Develops cloud-based software for healthcare payments.
- Provides financial clearance solutions for healthcare providers.
- Offers patient financial care tools to manage patient billing and payments.
- Manages claims and payment processing for healthcare organizations.
- Provides denial prevention and recovery solutions to minimize revenue loss.
- Offers revenue capture tools to optimize revenue cycle management.
- Delivers analytics and reporting solutions to track financial performance.
How Does WAY Make Money?
- Subscription-based revenue model: Charges recurring fees for access to its cloud-based platform.
- Value-based pricing: Offers pricing models aligned with the value delivered to healthcare providers.
- Data analytics services: Generates revenue from providing data analytics and reporting services.
- Implementation and training: Charges fees for implementation, training, and support services.
What Industry Does WAY Operate In?
Waystar Holding Corp. operates within the rapidly evolving healthcare information technology services sector. The industry is characterized by increasing demand for solutions that streamline administrative processes, improve revenue cycle management, and enhance patient financial experiences. Market trends include the adoption of cloud-based technologies, the integration of AI and machine learning, and a growing focus on data analytics. Waystar competes with established players and emerging startups, differentiating itself through its comprehensive platform and customer-centric approach. The healthcare IT market is projected to reach $440 billion by 2026, driven by regulatory changes, technological advancements, and the need for greater efficiency in healthcare operations.
Who Are WAY's Key Customers?
- Hospitals and health systems: Provides solutions to manage revenue cycle and improve financial performance.
- Physician practices: Offers tools to streamline billing and payment processes.
- Ambulatory surgery centers: Delivers solutions to optimize revenue capture and reduce administrative costs.
- Specialty clinics: Provides tailored solutions to meet the unique needs of specialty healthcare providers.
Waystar Holding Corp. (WAY) Valuation Context
Valued at $4.76B, WAY is classified as a mid-cap stock. Relative to its peer group, WAY's quantitative score of 80/100 is above the peer average of 51/100.
WAY Revenue & Earnings Trend
In Q2 2026, WAY generated $319.7M in top-line revenue, marking a sequential increase of 1.8%. The company recorded net income of $40.9M, with diluted EPS of $0.21. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this mid-cap Technology company. Across the four most recent quarters, WAY averaged $0.18 in diluted EPS.
Company Profile
Waystar Holding Corp. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Lehi, US. The company is led by CEO Matthew J. Hawkins. WAY has traded publicly since 2024.
Key Financial Metrics
Return on equity for Waystar Holding Corp. stands at 3.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 2.3%, showing how much profit it generates from its asset base. WAY trades at a trailing price-to-earnings ratio of 28.43, below the Technology sector average of ~34x. Its free cash flow yield is 5.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.85 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.8%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Waystar Holding Corp.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.88 places it in the grey zone, a middle ground that warrants monitoring.
Earnings Track Record
Waystar Holding Corp. has beaten Wall Street's EPS estimate in 6 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 18.3% above estimates on average.
Forward Outlook
Wall Street analysts project Waystar Holding Corp. revenue of about $1.29B for fiscal 2026, with EPS near $1.66. The estimate reflects 17 contributing analysts.
WAY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Comprehensive cloud-based platform for healthcare payments.
- Strong gross margin and profitability.
- Scalable business model.
- Experienced management team.
Bear Case
- Reliance on the healthcare industry.
- Limited geographic diversification.
- Potential for increased competition.
- Dependence on regulatory compliance.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $320M | $41M | $0.21 |
| Q1 2026 | $314M | $43M | $0.22 |
| Q4 2025 | $304M | $20M | $0.10 |
| Q3 2025 | $269M | $31M | $0.17 |
Based on FMP financials and quantitative analysis
WAY Latest News
-
This Adobe Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday
benzinga · Jul 2, 2026
-
This SkyWest Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday
benzinga · Jul 2, 2026
-
This Honeywell Aerospace Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
benzinga · Jul 2, 2026
WAY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for WAY.
Price Targets
Consensus target: $36.38
WAY MoonshotScore
What does this score mean?
The MoonshotScore rates WAY 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Latest News
This Adobe Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday
This SkyWest Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday
This Honeywell Aerospace Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Leadership: Matthew J. Hawkins
CEO
Matthew J. Hawkins is the Chief Executive Officer of Waystar Holding Corp. He brings extensive experience in the healthcare technology sector, with a proven track record of driving growth and innovation. Prior to joining Waystar, Hawkins held leadership positions at various healthcare IT companies, where he focused on developing and implementing solutions to improve healthcare financial performance. He holds a degree in Business Administration and has completed executive education programs at leading business schools. His expertise lies in strategic planning, product development, and customer relationship management.
Track Record: Under Matthew J. Hawkins' leadership, Waystar Holding Corp. has experienced significant growth and market expansion. He has spearheaded key strategic initiatives, including the development of new product offerings and the expansion into new healthcare verticals. Hawkins has also focused on building a strong company culture and fostering a customer-centric approach. During his tenure, Waystar has achieved significant milestones, including increased market share, improved customer satisfaction, and enhanced financial performance.
Waystar Holding Corp. Technology Stock: Key Questions Answered
What does the AI Score mean for WAY?
WAY holds an AI Score of 80/100 (Grade: A+). This is an educational research signal, not a buy or sell recommendation. Waystar Holding Corp. is a technology company providing cloud-based software solutions for healthcare payments. Their platform streamlines financial processes for healthcare providers, enhancing …
What does Waystar Holding Corp. do?
Waystar Holding Corp. is a technology company that develops and provides a cloud-based software platform for healthcare payments. Its platform offers a comprehensive suite of solutions designed to streamline the revenue cycle management process for healthcare providers. This includes financial clearance, patient financial care, claim and payment management, denial prevention and recovery, revenue capture, and analytics and reporting.
What do analysts say about WAY stock?
Analyst consensus on Waystar Holding Corp. (WAY) stock is generally positive, reflecting optimism about the company's growth prospects and market position. Key valuation metrics, such as the P/E ratio of 28.4, suggest a premium valuation, indicating high expectations for future earnings growth. Analysts highlight Waystar's strong gross margin of 65.2% as a positive indicator of efficient operations and pricing power.
What are the main risks for WAY?
The main risks for Waystar Holding Corp. include potential changes in healthcare regulations, which could impact the company's business model and require costly compliance measures. Cybersecurity threats and data breaches pose a significant risk, as a breach could damage Waystar's reputation and financial performance. An economic downturn could reduce healthcare spending and impact Waystar's revenue.
What are the key factors to evaluate for WAY?
Waystar Holding Corp. (WAY) holds an AI score of 80/100 (high). P/E: 28.4x vs the S&P 500's ~20-25x. Analysts target $36.38 (+46%). Not financial advice.
How frequently does WAY data refresh on this page?
WAY's price was last updated on Aug 20, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven WAY's recent stock price performance?
Waystar Holding Corp. (WAY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive cloud-based platform for healthcare payments. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider WAY overvalued or undervalued right now?
Waystar Holding Corp. (WAY) trades at 28.4x earnings. Analysts target $36.38 (+46%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research WAY before investing?
Before investing in Waystar Holding Corp. (WAY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- Financial metrics are as of the latest available reporting period.